现代中药集团(01643)拟于8月28日召开董事会 审议2026年中期业绩及股息方案

公告速递
Aug 13

现代中药集团有限公司(01643)8月13日公告,公司董事会将于2026年8月28日(星期五)召开会议。届时,董事会将审议并批准公司及其附属公司截至2026年6月30日止六个月的中期业绩,以及该业绩公告的发布事宜,并同时考虑派发中期股息的建议(如有)。

公告显示,现任董事会由三名执行董事和三名独立非执行董事组成。执行董事为孙新磊、张宏丽及贾艳茹;独立非执行董事为刘凌、梁子荣及黄志坚。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10